Current Position: Product Center
Anti-CD20 hIgG1 Reference Antibody (Ocrebio)
Cat. No.
GM-87986MAB
Size
Quote
Related products
Product Info
Cat. No. & Size
Description
Data
Related products
Product Info

Cat. No.:GM-87986MAB

Product:Anti-CD20 hIgG1 Reference Antibody (Ocrebio)


Cat. No. & Size

GM-87986MAB-1mg / 1 mg

GM-87986MAB-5mg / 5 mg

GM-87986MAB-25mg / 5 mg * 5 vials

GM-87986MAB-50mg / 50 mg

GM-87986MAB-100mg / 50 mg * 2 vials

Description

Expression System     CHO

Aggregation             < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          CD20

Clone                              Ocrelizumab

Alternative Names         B1, Bp35, MS4A1, CVID5, FMC7, LEU-16, S7

Source/Isotype           Monoclonal human IgG1(KEEM), Kappa

Application                      /

Description                 The CD20 gene encodes a transmembrane protein called CD20 (MS4A1), which is specifically expressed on the surface of B cells. Ocrelizumab is a humanized anti-CD20 monoclonal antibody that primarily induces B-cell lysis or apoptosis through two mechanisms: antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).

Formulation                phosphate-buffered solution, pH 7.2-7.4.


Data

image.png

image.png


Anti-CD20 hIgG1 Reference Antibody (Ocrebio)
Cat. No.
GM-87986MAB
Size
Quote
Related products
Product Info
Cat. No. & Size
Description
Data
Related products
Product Info

Cat. No.:GM-87986MAB

Product:Anti-CD20 hIgG1 Reference Antibody (Ocrebio)


Cat. No. & Size

GM-87986MAB-1mg / 1 mg

GM-87986MAB-5mg / 5 mg

GM-87986MAB-25mg / 5 mg * 5 vials

GM-87986MAB-50mg / 50 mg

GM-87986MAB-100mg / 50 mg * 2 vials

Description

Expression System     CHO

Aggregation             < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          CD20

Clone                              Ocrelizumab

Alternative Names         B1, Bp35, MS4A1, CVID5, FMC7, LEU-16, S7

Source/Isotype           Monoclonal human IgG1(KEEM), Kappa

Application                      /

Description                 The CD20 gene encodes a transmembrane protein called CD20 (MS4A1), which is specifically expressed on the surface of B cells. Ocrelizumab is a humanized anti-CD20 monoclonal antibody that primarily induces B-cell lysis or apoptosis through two mechanisms: antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).

Formulation                phosphate-buffered solution, pH 7.2-7.4.


Data

image.png

image.png


Message consultation
reset
submit
Message
Message consultation
reset
submit